ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KMK Kromek Group Plc

7.50
0.50 (7.14%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 7.14% 7.50 7.30 7.70 7.75 7.25 7.25 2,321,457 15:18:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.35 45.02M

Kromek Group PLC New $12.6m contract with existing OEM customer (5831W)

28/04/2016 7:01am

UK Regulatory


Kromek (LSE:KMK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Kromek Charts.

TIDMKMK

RNS Number : 5831W

Kromek Group PLC

28 April 2016

28 April 2016

Kromek Group plc

("Kromek" or the "Company")

Kromek secures a five-year contract totalling $12.6m with long-standing OEM customer

Development and supply of detectors for launch of new generation of bone mineral densitometry systems

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce that it has been awarded a new contract with a current OEM customer, a worldwide producer and exporter of bone mineral density ("BMD") diagnostics systems, for developing and supplying detectors to be incorporated into the customer's new generation systems. The contract, worth $12.6m, is expected to start during the first half of the financial year to 30 April 2017 and to be delivered over a 5-year period.

Under the terms of the agreement, Kromek's detector modules will be incorporated into the customer's systems to produce some of the most accurate imaging to diagnose the strength and health of bones. The new generation of diagnostic systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.

Arnab Basu, CEO of Kromek, said: "It is very pleasing to secure such a significant contract from a long-standing customer. It strengthens our relationship with them and further validates the benefits of our BMD diagnostic systems. The agreement represents the continued healthy conversion of our pipeline into orders as we continue to win new business in the medical sector and across our key target markets of SPECT, CT and networked radiation detectors."

Enquiries

 
 Kromek Group plc 
--------------------------------  --------------- 
 Arnab Basu, CEO                   +44 (0)1740 
  Derek Bulmer, CFO                 626 060 
--------------------------------  --------------- 
 
 Cenkos Securities plc 
--------------------------------  --------------- 
 Bobbie Hilliam (NOMAD)            +44 (0)20 7397 
  Julian Morse (Sales)              8900 
--------------------------------  --------------- 
 
 Luther Pendragon Ltd 
--------------------------------  --------------- 
 Harry Chathli, Claire Norbury,    +44 (0)20 7618 
  Alexis Gore                       9100 
--------------------------------  --------------- 
 

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology, Kromek designs develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

CNTAKODDKBKBAQB

(END) Dow Jones Newswires

April 28, 2016 02:01 ET (06:01 GMT)

1 Year Kromek Chart

1 Year Kromek Chart

1 Month Kromek Chart

1 Month Kromek Chart

Your Recent History

Delayed Upgrade Clock